Quinn Opportunity Partners’s Bristol-Myers Squibb BMY Stock Holding History

Quinn Opportunity Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-109,000	Closed	-$6.8M	–	174
2021 Q4	$6.8M	Hold	109,000	–	–	0.41%	55
2021 Q3	$6.45M	Hold	109,000	–	–	0.41%	49
2021 Q2	$7.28M	Sell	109,000 -12,702	-10%	-$828K	0.45%	48
2021 Q1	$7.68M	Buy	121,702 +43,053	+55%	+$2.68M	0.49%	45
2020 Q4	$4.88M	Buy	+78,649	New	+$4.84M	0.41%	49
2019 Q2	–	Sell	-30,900	Closed	-$1.47M	–	194
2019 Q1	$1.47M	Buy	+30,900	New	+$1.54M	0.2%	63

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Quinn Opportunity Partners's BMY Position: Q1 2022 in Review

Quinn Opportunity Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 109,000 shares — an estimated $6.8M sold.

Quinn Opportunity Partners first reported a position in BMY in Q1 2019 and held it in 6 quarters. The position peaked at $7.68M in Q1 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

Quinn Opportunity Partners reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
Quinn Opportunity Partners sold 109,000 Bristol-Myers Squibb shares in Q1 2022, an estimated $6.8M.
Quinn Opportunity Partners first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 6 quarters.
Quinn Opportunity Partners's Bristol-Myers Squibb position peaked at $7.68M in Q1 2021.
2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Quinn Opportunity Partners's 13F filing for Q1 2022, filed 16 May 2022.